CLUSTER filed Jun 9, 2026 at 20:32 ET
A cluster of insider sales at ABEO Therapeutics: CEO, CFO, Chief Commercial Officer, and Chief Legal Officer collectively sold ~$540K in open-market transactions over two days (June 8-9, 2026) at ~$5.30-$5.43/share. While the dollar amount is modest relative to the $307M market cap (~0.18%), the participation of the entire C-suite in a coordinated sell-off is notable. The cluster is amplified by cross-filing context (cluster-insider-trades + cluster-offering-context), suggesting potential upcoming dilutive activity or other material developments.